109 related articles for article (PubMed ID: 22781112)
1. [Analysis of the status of DACH1 gene promoter methylation in endometrial carcinoma and its clinical significance].
Deng XC; Li SR; Zhang Q; Zhou CJ; Yang QF; Jiang J; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):263-7. PubMed ID: 22781112
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR.
Shih MC; Yeh KT; Tang KP; Chen JC; Chang JG
Mol Carcinog; 2006 Oct; 45(10):732-40. PubMed ID: 16683245
[TBL] [Abstract][Full Text] [Related]
4. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
5. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
6. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
7. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
9. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
[TBL] [Abstract][Full Text] [Related]
10. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
[TBL] [Abstract][Full Text] [Related]
11. [Significance of methylation and abnormal expression of p16 gene in endometrial carcinoma].
Yuan JR; Fu SB; Fu H; Li P
Yi Chuan Xue Bao; 2004 May; 31(5):454-9. PubMed ID: 15478604
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling.
Yan W; Wu K; Herman JG; Brock MV; Zhou Y; Lu Y; Zhang Z; Yang Y; Guo M
J Cell Mol Med; 2014 Dec; 18(12):2499-511. PubMed ID: 24912879
[TBL] [Abstract][Full Text] [Related]
15. [Expression and methylation of adenomatous polyposis coli gene in endometrioid adenocarcinoma].
Qian B; Ke PQ; Wang L; Liu WJ; Li MX
Ai Zheng; 2008 Jun; 27(6):585-9. PubMed ID: 18570730
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation.
Akahira J; Suzuki F; Suzuki T; Miura I; Kamogawa N; Miki Y; Ito K; Yaegashi N; Sasano H
Pathol Int; 2007 Nov; 57(11):725-33. PubMed ID: 17922684
[TBL] [Abstract][Full Text] [Related]
18. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.
Salvesen HB; Das S; Akslen LA
Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444
[TBL] [Abstract][Full Text] [Related]
19. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation.
Brevet M; Fucks D; Chatelain D; Regimbeau JM; Delcenserie R; Sevestre H; Ouadid-Ahidouch H
Pancreas; 2009 Aug; 38(6):649-54. PubMed ID: 19465885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
